Bulletin
Investor Alert

NeuBase Therapeutics Inc.

NAS: NBSE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 15, 2021, 4:00 p.m.

/zigman2/quotes/206101919/composite

$

3.94

Change

0.00 0.00%

Volume

Volume 712

Quotes are delayed by 20 min

/zigman2/quotes/206101919/composite

Previous close

$ 4.05

$ 3.94

Change

-0.11 -2.72%

Day low

Day high

$3.70

$4.10

Open

52 week low

52 week high

$3.26

$12.89

Open

Insider Actions for NeuBase Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/18/2021 Dov A. Goldstein
Director
8,000   Acquisition at $4.75 per share. 38,000
04/26/2021 Dietrich A. Stephan
President and CEO; Director
12,000   Acquisition at $5 per share. 60,000
04/26/2021 Eric I. Richman
Director
5,000   Acquisition at $5 per share. 25,000
04/26/2021 Dov A. Goldstein
Director
12,000   Acquisition at $5 per share. 60,000
04/26/2021 William R. Mann
COO
5,000   Acquisition at $5 per share. 25,000
12/01/2020 Dietrich A. Stephan
President and CEO; Director
1,273,820   Gift at $0 per share. 0
12/01/2020 Dietrich A. Stephan
President and CEO; Director
1,273,819   Gift at $0 per share. 0
11/30/2020 Dietrich A. Stephan
President and CEO; Director
1,273,819   Gift at $0 per share. 0
11/23/2020 Dietrich A. Stephan
President and CEO; Director
2,547,639   Gift at $0 per share. 0
06/09/2020 Dietrich A. Stephan
President and CEO; Director
1,275   Acquisition at $7.73 per share. 9,855
05/21/2020 Dietrich A. Stephan
President and CEO; Director
1,250   Acquisition at $8.09 per share. 10,112
04/30/2020 Dietrich A. Stephan
President and CEO; Director
10,000   Acquisition at $6 per share. 60,000
04/30/2020 Eric I. Richman
Director
8,333   Acquisition at $6 per share. 49,998
04/30/2020 Eric I. Richman
Director
2,500   Acquisition at $6 per share. 15,000
04/30/2020 Dov A. Goldstein
Director
10,000   Acquisition at $6 per share. 60,000
04/30/2020 Samuel I. Backenroth
CFO, Treasurer & Secretary
1,000   Acquisition at $6 per share. 6,000
07/12/2019 Dietrich A. Stephan
President and CEO; Director
2,547,639   Award at $0 per share. 0
07/12/2019 Eric I. Richman
Director
25,247   Award at $0 per share. 0
04/10/2017 Samuel I. Backenroth
CFO, Treasurer & Secretary
71,429   Acquisition at $0.7 per share. 50,000
04/10/2017 AIGH Capital Management LLC
Director
171,429   Acquisition at $0.7 per share. 120,000
04/10/2017 Jason Scott Slakter
Chief Executive Officer; Director
142,858   Acquisition at $0.7 per share. 100,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
5 Purchases
0 Sales
42,000
0
Last 12 months
5 Purchases
4 Sales
42,000
6,369,097

Officers and Executives

Dr. Dietrich A. Stephan
Chairman, President, CEO & Chief Financial Officer
Dr. William R. Mann
Chief Operating Officer
Mr. Robert Friedlander
Chief Medical Officer
Dr. Curt W. Bradshaw
Chief Scientific Officer
Dr. Sandra Porcile Rojas-Caro
Chief Medical Officer
Dr. Anthony Rossomando
Chief Technology Officer
Dr. Kianoush Motesharei
Chief Business & Strategy Officer
Ms. Shannon McCarthy
Chief People Officer
Dr. Dov A. Goldstein
Independent Director
Dr. Franklyn G. Prendergast
Independent Director
Mr. Eric I. Richman
Independent Director
Mr. Gerald J. McDougall
Independent Director
Trending Tickers
  • /zigman2/quotes/203240833/composite ASG-0.56%
  • /zigman2/quotes/200272047/composite OI-1.52%
  • /zigman2/quotes/201842100/composite DISCK-2.18%
  • /zigman2/quotes/208424563/composite GRFS-2.16%
  • /zigman2/quotes/202258849/composite COOP+2.03%
X
Powered by StockTwits
Link to MarketWatch's Slice.